Clinical Trials Browser

OTHER × Antibodies, Bispecific × Clear all

NCT07051850 2025-07-15

Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies

Multiple Myeloma, Recurrence

NCT06904131 2025-04-01

A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors

Phase NA Recruiting

Other solid neoplasm

Gynecological Solid Tumors

NCT06796517 2025-01-28

Immunotherapy in Lymphoma

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT05119257 2024-05-08

InHeAb01

Neoplasms

NCT06404736 2024-05-08

QUEEN-Dream

Phase 2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00014560 2018-05-03

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Phase 1 Terminated

3 enrolled 3 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00467506 2011-11-11

RIT in MTC

Phase 2 Completed

Thyroid Neoplasms

NCT00149019 2011-04-08

Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.

Phase 2 Withdrawn

Other solid neoplasm

Metastatic Solid Tumors